KOSDAQ · Healthcare · ₩203B
₩6,100-1.77%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 8.2% · as of 26.10.27
Among 97 제약 peers
Quarterly Revenue Growth
“생산 확대 기대는 살아 있지만 실적 회복 확인이 먼저예요.”
In the company's words · 2026 2분기 filing